[Effects of (+)-catechin and epigallocatechin gallate on alcoholic fatty liver in mice models]
- PMID: 34749473
- DOI: 10.3760/cma.j.cn112150-20201102-01264
[Effects of (+)-catechin and epigallocatechin gallate on alcoholic fatty liver in mice models]
Abstract
Objective: To investigate the effects of (+)-catechin and epigallocatechin gallate (EGCG) on alcoholic fatty liver in mice models. Methods: Alcohol and high-fat diet were used to construct the model of alcoholic fatty liver disease, and treated the model with (+)-catechin and EGCG. The effects of (+)-catechin and EGCG were analyzed by detecting the contents of TG, TC, MDA, SOD, ALT and AST in serum and pathological changes of liver. Results: (+)-catechin and EGCG could effectively reduce the contents of TG, TC, MDA, ALT and AST, increase the content of SOD in serum of mice with alcoholic fatty liver disease, improve the degree of liver cell edema and reduce the formation of lipid droplets. Conclusion: (+)-catechin and EGCG could repair liver injury and regulate lipid metabolism of hepatocytes in alcoholic fatty liver disease mice models.
目的: 研究(+)-儿茶素和表没食子儿茶素没食子酸酯(EGCG)对酒精性脂肪性肝病(AFLD)小鼠脂肪肝的影响。 方法: 使用酒精和高脂饮食构建小鼠AFLD模型,建模成功后加以(+)-儿茶素和EGCG干预,并通过检测小鼠血清中甘油三酯(TG)、总胆固醇(TC)、丙二醛(MDA)、超氧化物歧化酶(SOD)、丙氨酸氨基转移酶(ALT)、门冬氨酸氨基转移酶(AST)含量及肝脏病理变化,分析(+)-儿茶素和EGCG对小鼠脂肪肝的影响。 结果: (+)-儿茶素和EGCG均可有效降低AFLD模型小鼠血清中的TG、TC、MDA、ALT和AST含量,升高SOD含量,并改善小鼠肝细胞水肿程度、减少脂滴形成。 结论: (+)-儿茶素和EGCG可修复AFLD模型小鼠的肝损伤、调节肝细胞脂代谢。.
Similar articles
-
Epigallocatechin gallate suppresses hepatic cholesterol synthesis by targeting SREBP-2 through SIRT1/FOXO1 signaling pathway.Mol Cell Biochem. 2018 Nov;448(1-2):175-185. doi: 10.1007/s11010-018-3324-x. Epub 2018 Feb 14. Mol Cell Biochem. 2018. PMID: 29446047
-
Effect of dietary epigallocatechin-3-gallate on cytochrome P450 2E1-dependent alcoholic liver damage: enhancement of fatty acid oxidation.Biosci Biotechnol Biochem. 2007 Dec;71(12):2999-3006. doi: 10.1271/bbb.70403. Epub 2007 Dec 7. Biosci Biotechnol Biochem. 2007. PMID: 18071271
-
Epigallocatechin-3-Gallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile and Macrophage Polarization.Nutrients. 2021 Feb 11;13(2):599. doi: 10.3390/nu13020599. Nutrients. 2021. PMID: 33670347 Free PMC article.
-
Potential Biological Effects of (-)-Epigallocatechin-3-gallate on the Treatment of Nonalcoholic Fatty Liver Disease.Mol Nutr Food Res. 2018 Jan;62(1):1700483. doi: 10.1002/mnfr.201700483. Epub 2017 Oct 12. Mol Nutr Food Res. 2018. PMID: 28799714 Free PMC article. Review.
-
Therapeutic Activity of Green Tea Epigallocatechin-3-Gallate on Metabolic Diseases and Non-Alcoholic Fatty Liver Diseases: The Current Updates.Nutrients. 2023 Jul 3;15(13):3022. doi: 10.3390/nu15133022. Nutrients. 2023. PMID: 37447347 Free PMC article. Review.
Cited by
-
Traditional Chinese medicine monomers: Targeting pulmonary artery smooth muscle cells proliferation to treat pulmonary hypertension.Heliyon. 2023 Mar 25;9(4):e14916. doi: 10.1016/j.heliyon.2023.e14916. eCollection 2023 Apr. Heliyon. 2023. PMID: 37128338 Free PMC article. Review.
-
Epigallocatechin-3-Gallate Alleviates Liver Oxidative Damage Caused by Iron Overload in Mice through Inhibiting Ferroptosis.Nutrients. 2023 Apr 21;15(8):1993. doi: 10.3390/nu15081993. Nutrients. 2023. PMID: 37111212 Free PMC article.
-
Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease.Front Pharmacol. 2022 Sep 16;13:1005312. doi: 10.3389/fphar.2022.1005312. eCollection 2022. Front Pharmacol. 2022. PMID: 36188561 Free PMC article. Review.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
